Rapid is committed to meeting the needs of customers by providing superior quality products. Every member of the Rapid team strives to assure that our products meet the highest regulatory, statutory and customer requirement standards.
We are continuously improving to maintain an effective quality management system. An integral part of our quality system is that we incorporate ethics into our business practices and also recognize the importance of advancing the interests of our stakeholders.
Quality Policy
Quality Policy
our Policy
Rapid is committed to meeting the needs of customers by providing superior quality products. Every member of the Rapid team strives to assure that our products meet the highest regulatory, statutory and customer requirement standards.
We are continuously improving to maintain an effective quality management system. An integral part of our quality system is that we incorporate ethics into our business practices and also recognize the importance of advancing the interests of our stakeholders.
Our Policy
About us
Radiopharmaceutical Imaging and Dosimetry, LLC (Rapid), is a Baltimore based company providing comprehensive expert service and software solutions related to quantitative imaging, dosimetry, in support of pre-clinical and clinical studies.
Contact us
Learn more about our products get in touch with us
Financial Conflict of Interest in PHS-Funded Projects Policy
I. Policy
Radiopharmaceutical Imaging and Dosimetry, LLC (Rapid) strives to create a research climate that promotes objectivity in research by establishing standards such that the design, conduct and reporting of Public Health Service (PHS, which includes NIH) funded research is free from bias resulting from financial conflict of interest (FCOI).
Rapid FCOI policy consists of:
1. Policy and procedure: Financial Conflict of Interest in PHS-Funded Projects.
2. Protocol: Protocol for Handling Financial Conflict of Interest.
This policy is applicable to each employee who is planning to or is participating in research activity that is either partially or wholly supported by PHS funds. Each such employee must:
1. Disclose his/her significant financial interests (SFI) in non-Rapid entities that would appear to be related to the employee’s professional responsibilities on behalf of Rapid;
2. Comply with a FCOI management plan, if a FCOI is identified; and 3. Undergo FCOI training, at least once every four years.
Disclosure of SFI is essential for Rapid to determine if a FCOI exists, and in cases of FCOI determine how it will be managed and reported in full compliance with government regulation. Non-disclosure of SFI or non-compliance with FCOI management plan may subject the employee to employment discipline including, without limitation, suspension or termination of employment.